Senior researcher at the Biomaterials for Regenerative Therapies Research Group (SR_EE)
Ref: SR-EE/Deadline: 28/11/2023
Elisabeth Engel
Group leader
Bioaction Project: Turning Infections from Health Risk to Opportunity
Bioaction is an EU-funded project, in which IBEC is involved, that aims to revolutionize the approach to implant-associated infections. By harnessing hydrogels and smart nanomaterials, Bioaction will transform bacterial biofilms into bio-factories for tissue regeneration, offering a novel alternative to traditional antibiotic therapies. The project is driven by a multidisciplinary team of experts and strives to improve patient outcomes while addressing the global challenge of antimicrobial resistance.
Elisabeth Engel and Gabriel Gomila receive the ICREA Acadèmia grant
IBEC researchers Elisabeth Engel and Gabriel Gomila have been awarded the “ICREA Acadèmia” distinction by the Catalan Institution for Research and Advanced Studies (ICREA). Engel and Gomila, who lead their … Read more
The President of Catalonia visits IBEC
During the visit, the President of the Government of Catalonia, Pere Aragonès i Garcia, and the Minister of Health, Manel Balcells i Díaz, were able to learn first-hand about several … Read more
3D bioprinting on RTVE
Lead researcher Eli Engel and IBEC researcher Bárbara Blanco are featured on RTVE for their recent research against breast cancer. Using 3D bioprinting they have created tumors from pig tissue. … Read more
3D bioprinting and cancer in the media
IBEC researchers led by Elisabeth Engel are in the media for their new tool against breast cancer: 3D bioprinting of tumors using pig tissue. The study, led by group leader … Read more
PostDoc Researcher at the Biomaterials for Regenerative Therapies Research Group
Ref: PostDoc / Deadline: 31st July 2022
A new tool against breast cancer: 3D bioprinted tumors using pig tissue
Researchers at IBEC manage to recreate the complex composition of human breast tumors in the laboratory using tissues from female pig breasts. This new model will allow, among other applications, the production of artificial tumors to study the development of cancer and metastasis, and immunosuppression processes, as well as being an excellent platform for testing drugs against the disease.
Zaida Álvarez wins the Rafael Hervada prize
At the press conference held this morning at the San Rafael Hospital, the Rafael Hervada prize was announced. Zaida Álvarez, current researcher at IBEC, has been awarded for her pioneering research on regeneration of spinal cord injuries using nanotechnology at the Northwestern University, Chicago, USA.
Biomaterials made at IBEC reach the Bulgarian press
